Covering Madness


One blog that is worth paying close attention to in this space is Mad in America: History Science and Psychiatry, a comprehensive look at mental illness treatment and pharmaceuticals written by Robert Whitaker, author of a number of books on the subject.

Whitaker’s eponymous Mad in America: Bad Medicine, Bad Science and the Continued Mistreatment of the Mentally Ill, published in 2010, was called, “One of the most disturbing, consequential works of investigative journalism I’ve read in a long time. Perhaps ever,” by John Horgan in Scientific AmericanWhitaker’s more recent Anatomy of an Epidemic, from 2011, examines whether psychiatric drugs are behind the meteoric rise in mental illness in the United States over the past fifty years. “In 1955, there were 355,000 adults in state and county mental hospitals with psychiatric diagnosis. During the next three decades (the era of the first generation psychiatric drugs), the number of disabled mentally ill rose to 1.25 million,” he writes in one post on the blog. The book attempts to answer that question—are doctor-prescribed pharmaceuticals inducing mental illness?—with a look at the science, and the blog is meant to provide readers with access to the studies that the book examines as well as to provide ongoing coverage of news on mental illness treatment, pharmaceutical company malfeasance and drug side effects in the U.S. Continue reading

In Treatment

Schizophrenia, a term coined in 1908 by Eugen Bleuler, is one of the most difficult mental illnesses to treat. Rates of recovery today are no better than they were 100 years ago. Antipsychotics, which target dopamine receptors in the brain, are the most common model of treatment, though the side effects can be crippling and permanent, and may even worsen the symptoms and prevent recovery. Part of the problem is that schizophrenia as biomedical concept has not been validated. Research has shown that people with schizophrenia and schizoaffective disorders tend to have abnormalities in the metabolism of tetrahydrobiopterin, dopamine, and glutamate, but how these abnormalities might cause the symptoms of schizophrenia is not understood. The illness has been shown to run in families, but specific genes have not yet been identified.

Some doctors are trying alternatives to drugs, like cognitive behavioral therapy, a kind of talk therapy that involves actively reorienting one’s thought patterns. It has been used to treat depression for over a decade, but some research suggests it may also be effective at treating schizophrenia.

Some believe schizophrenics are better off learning to cope with their voices, including journalist Robert Whitaker, who writes about it at his website Mad in America. In fact, studies have shown that schizophrenics in developing countries, where antipsychotics are less widely available, have better rates of long-term recovery than those in developed nations. Continue reading